The Theory of Hyperlipidemic Memory of Type 1 Diabetes

Literature Search CriteriaA literature search was conducted to identify publications addressing the early phases of lipid phenotypes in children and adults with either type 1 diabetes or type 2 diabetes. Medline, EMBASE, and Ovid were searched using the following search terms: clinical remission, pa...

Full description

Bibliographic Details
Main Author: Benjamin Udoka Nwosu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.819544/full
_version_ 1818311209067216896
author Benjamin Udoka Nwosu
Benjamin Udoka Nwosu
author_facet Benjamin Udoka Nwosu
Benjamin Udoka Nwosu
author_sort Benjamin Udoka Nwosu
collection DOAJ
description Literature Search CriteriaA literature search was conducted to identify publications addressing the early phases of lipid phenotypes in children and adults with either type 1 diabetes or type 2 diabetes. Medline, EMBASE, and Ovid were searched using the following search terms: clinical remission, partial remission, partial clinical remission, honeymoon phase, C-peptide, type 1 or 2 diabetes, children, pediatric type 1 or 2 diabetes, and paediatrics type 1 or 2 diabetes, adults, adult type 1 or type 2 diabetes.Partial clinical remission (PR) of type 1 diabetes (T1D) is characterized by continued endogenous production of insulin and C-peptide following the diagnosis and the introduction of exogenous insulin therapy. PR is associated with improved glycemic control and reduced prevalence of diabetes complications. The theory of hyperglycemic memory was proposed to explain this concept of improved glycemic outcomes in remitters (those who experienced PR) versus non-remitters (those who did not experience PR). However, this theory is incomplete as it does not explain the dichotomy in early lipid phenotypes in T1D based on PR status, which is an understudied area in diabetology and lipidology. To fill this knowledge gap, we propose the Theory of Hyperlipidemic Memory of T1D. This theory is premised on our 5-year research on early post-diagnostic dichotomy in lipid phenotypes between remitters and non-remitters across the lifespan. It provides a more rigorous explanation for the differences in lifelong atherosclerotic cardiovascular disease (ASCVD) risk between remitters and non-remitters. We conducted 4 clinical studies in pediatric and adult subjects with diabetes mellitus to characterize the particulars of the hyperlipidemic memory. In the first investigation, we explored the impact of the presence or absence of PR on lipid parameters in children and adolescents with T1D. In the second, we investigated whether pubertal maturation influenced our findings in T1D; and whether these findings could be replicated in healthy, non-diabetic children and adolescents. In the third, we leveraged our findings from T1D and controls to investigate the mechanisms of early lipid changes in T2D by comparing the earliest lipid phenotype of subjects with type 2 diabetes (T2D) to those of remitters, non-remitters, and controls. In the fourth, we investigated the impact of PR on the earliest lipid phenotypes in adults with T1D and compared these early lipid data to those of T2D subjects and controls. This body of work across the lifespan in children, adolescents, and adults supports the Theory of Hyperlipidemic Memory. This new theory clarifies why PR largely determines the risks for early-phase dyslipidemia, mid-term microvascular disease risk, and long-term ASCVD risk in subjects with T1D.
first_indexed 2024-12-13T07:58:19Z
format Article
id doaj.art-d4fb354f84f7452fa58b915f2d917f96
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-13T07:58:19Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-d4fb354f84f7452fa58b915f2d917f962022-12-21T23:54:29ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-03-011310.3389/fendo.2022.819544819544The Theory of Hyperlipidemic Memory of Type 1 DiabetesBenjamin Udoka Nwosu0Benjamin Udoka Nwosu1Division of Endocrinology, Department of Pediatrics, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, United StatesDivision of Endocrinology, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA, United StatesLiterature Search CriteriaA literature search was conducted to identify publications addressing the early phases of lipid phenotypes in children and adults with either type 1 diabetes or type 2 diabetes. Medline, EMBASE, and Ovid were searched using the following search terms: clinical remission, partial remission, partial clinical remission, honeymoon phase, C-peptide, type 1 or 2 diabetes, children, pediatric type 1 or 2 diabetes, and paediatrics type 1 or 2 diabetes, adults, adult type 1 or type 2 diabetes.Partial clinical remission (PR) of type 1 diabetes (T1D) is characterized by continued endogenous production of insulin and C-peptide following the diagnosis and the introduction of exogenous insulin therapy. PR is associated with improved glycemic control and reduced prevalence of diabetes complications. The theory of hyperglycemic memory was proposed to explain this concept of improved glycemic outcomes in remitters (those who experienced PR) versus non-remitters (those who did not experience PR). However, this theory is incomplete as it does not explain the dichotomy in early lipid phenotypes in T1D based on PR status, which is an understudied area in diabetology and lipidology. To fill this knowledge gap, we propose the Theory of Hyperlipidemic Memory of T1D. This theory is premised on our 5-year research on early post-diagnostic dichotomy in lipid phenotypes between remitters and non-remitters across the lifespan. It provides a more rigorous explanation for the differences in lifelong atherosclerotic cardiovascular disease (ASCVD) risk between remitters and non-remitters. We conducted 4 clinical studies in pediatric and adult subjects with diabetes mellitus to characterize the particulars of the hyperlipidemic memory. In the first investigation, we explored the impact of the presence or absence of PR on lipid parameters in children and adolescents with T1D. In the second, we investigated whether pubertal maturation influenced our findings in T1D; and whether these findings could be replicated in healthy, non-diabetic children and adolescents. In the third, we leveraged our findings from T1D and controls to investigate the mechanisms of early lipid changes in T2D by comparing the earliest lipid phenotype of subjects with type 2 diabetes (T2D) to those of remitters, non-remitters, and controls. In the fourth, we investigated the impact of PR on the earliest lipid phenotypes in adults with T1D and compared these early lipid data to those of T2D subjects and controls. This body of work across the lifespan in children, adolescents, and adults supports the Theory of Hyperlipidemic Memory. This new theory clarifies why PR largely determines the risks for early-phase dyslipidemia, mid-term microvascular disease risk, and long-term ASCVD risk in subjects with T1D.https://www.frontiersin.org/articles/10.3389/fendo.2022.819544/fulltype 1 diabetestype 2 diabetesadultshoneymoon phasepartial clinical remissioncardiovascular disease risk
spellingShingle Benjamin Udoka Nwosu
Benjamin Udoka Nwosu
The Theory of Hyperlipidemic Memory of Type 1 Diabetes
Frontiers in Endocrinology
type 1 diabetes
type 2 diabetes
adults
honeymoon phase
partial clinical remission
cardiovascular disease risk
title The Theory of Hyperlipidemic Memory of Type 1 Diabetes
title_full The Theory of Hyperlipidemic Memory of Type 1 Diabetes
title_fullStr The Theory of Hyperlipidemic Memory of Type 1 Diabetes
title_full_unstemmed The Theory of Hyperlipidemic Memory of Type 1 Diabetes
title_short The Theory of Hyperlipidemic Memory of Type 1 Diabetes
title_sort theory of hyperlipidemic memory of type 1 diabetes
topic type 1 diabetes
type 2 diabetes
adults
honeymoon phase
partial clinical remission
cardiovascular disease risk
url https://www.frontiersin.org/articles/10.3389/fendo.2022.819544/full
work_keys_str_mv AT benjaminudokanwosu thetheoryofhyperlipidemicmemoryoftype1diabetes
AT benjaminudokanwosu thetheoryofhyperlipidemicmemoryoftype1diabetes
AT benjaminudokanwosu theoryofhyperlipidemicmemoryoftype1diabetes
AT benjaminudokanwosu theoryofhyperlipidemicmemoryoftype1diabetes